FOLD
Price
$9.44
Change
-$0.29 (-2.98%)
Updated
Nov 20, 04:59 PM (EDT)
Capitalization
2.91B
91 days until earnings call
Intraday BUY SELL Signals
PEPG
Price
$5.10
Change
-$0.43 (-7.78%)
Updated
Nov 20, 04:59 PM (EDT)
Capitalization
380.18M
119 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

FOLD vs PEPG

Header iconFOLD vs PEPG Comparison
Open Charts FOLD vs PEPGBanner chart's image
Amicus Therapeutics
Price$9.44
Change-$0.29 (-2.98%)
Volume$82.62K
Capitalization2.91B
PepGen
Price$5.10
Change-$0.43 (-7.78%)
Volume$17.13K
Capitalization380.18M
FOLD vs PEPG Comparison Chart in %
FOLD
Daily Signal:
Gain/Loss:
PEPG
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
FOLD vs. PEPG commentary
Nov 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FOLD is a Hold and PEPG is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 21, 2025
Stock price -- (FOLD: $9.73 vs. PEPG: $5.53)
Brand notoriety: FOLD and PEPG are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FOLD: 76% vs. PEPG: 19%
Market capitalization -- FOLD: $2.91B vs. PEPG: $380.18M
FOLD [@Biotechnology] is valued at $2.91B. PEPG’s [@Biotechnology] market capitalization is $380.18M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.15B to $0. The average market capitalization across the [@Biotechnology] industry is $2.12B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FOLD’s FA Score shows that 0 FA rating(s) are green whilePEPG’s FA Score has 1 green FA rating(s).

  • FOLD’s FA Score: 0 green, 5 red.
  • PEPG’s FA Score: 1 green, 4 red.
According to our system of comparison, PEPG is a better buy in the long-term than FOLD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FOLD’s TA Score shows that 4 TA indicator(s) are bullish while PEPG’s TA Score has 4 bullish TA indicator(s).

  • FOLD’s TA Score: 4 bullish, 4 bearish.
  • PEPG’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, PEPG is a better buy in the short-term than FOLD.

Price Growth

FOLD (@Biotechnology) experienced а +3.24% price change this week, while PEPG (@Biotechnology) price change was +7.80% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.63%. For the same industry, the average monthly price growth was -6.94%, and the average quarterly price growth was +61.81%.

Reported Earning Dates

FOLD is expected to report earnings on Feb 19, 2026.

PEPG is expected to report earnings on Mar 19, 2026.

Industries' Descriptions

@Biotechnology (-1.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FOLD($2.91B) has a higher market cap than PEPG($380M). PEPG YTD gains are higher at: 45.910 vs. FOLD (3.238). FOLD has higher annual earnings (EBITDA): 33.1M vs. PEPG (-97.54M). FOLD has more cash in the bank: 231M vs. PEPG (74.7M). PEPG has less debt than FOLD: PEPG (17.9M) vs FOLD (443M). FOLD has higher revenues than PEPG: FOLD (571M) vs PEPG (0).
FOLDPEPGFOLD / PEPG
Capitalization2.91B380M767%
EBITDA33.1M-97.54M-34%
Gain YTD3.23845.9107%
P/E RatioN/AN/A-
Revenue571M0-
Total Cash231M74.7M309%
Total Debt443M17.9M2,475%
FUNDAMENTALS RATINGS
FOLD: Fundamental Ratings
FOLD
OUTLOOK RATING
1..100
23
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FOLDPEPG
RSI
ODDS (%)
Bearish Trend 2 days ago
69%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 3 days ago
87%
Declines
ODDS (%)
Bearish Trend 14 days ago
75%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
FOLD
Daily Signal:
Gain/Loss:
PEPG
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TEGAX40.46N/A
N/A
Touchstone Mid Cap Growth A
FIQDX8.85N/A
N/A
Fidelity Advisor Strategic Real Ret Z
RPBAX29.13N/A
N/A
T. Rowe Price Balanced
ASQGX17.17N/A
N/A
American Century Small Company R5
WWMCX11.59N/A
N/A
Westwood Quality Midcap Institutional

PEPG and

Correlation & Price change

A.I.dvisor tells us that PEPG and TRDA have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PEPG and TRDA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PEPG
1D Price
Change %
PEPG100%
-3.66%
TRDA - PEPG
32%
Poorly correlated
-0.91%
FOLD - PEPG
30%
Poorly correlated
+1.41%
LEXX - PEPG
30%
Poorly correlated
+4.76%
FULC - PEPG
29%
Poorly correlated
+18.40%
FENC - PEPG
29%
Poorly correlated
-6.51%
More